COVID-19 has impacted our lives in many ways, including healthcare. During this webinar you’ll gain an understanding of patients’ experiences of health care at a distance and how telehealth will impact pharma strategies. Our discussion focused on how COVID-19 affected patients’ interactions with HCPs, patients’ perceptions of the quality of care via telehealth and the differences in experiences and perceptions between countries.

Topics we covered:

  • Initial patients’ experiences of the transition to care at a distance proved to be positive, however, it’s important to realize that this may not be a lasting impression.
  • Setting patients at the heart of redefining strategies becomes a must. Patient centricity takes a new dimension in digital care/care at a distance.
  • Empowering patients to play a relevant role in the decision-making process is more imperative than ever, especially now that the right treatment is based on a patient’s ability to communicate their physical and mental health, via a web-based video conferencing platform.

Date & Time: March 10, 11 am ET
Location: Virtual


Janneke van den Bent
Bill Salokar
VP Client Solutions